OBJECTIVE: Our objective was to determine factors associated with adiponectin levels in subjects with stage III to IV chronic kidney disease (CKD). DESIGN: We used a cross-sectional analysis. SETTING: All kidney-disease subjects and controls were recruited at Vanderbilt University Medical Center (Nashville, TN) and Maine Medical Center (Portland, ME). PATIENTS: We recruited 95 stage III to IV CKD subjects. Kidney-disease subjects with history of diabetes mellitus were excluded from the study. INTERVENTIONS: There were no interventions. RESULTS: Subjects with stage IV CKD had significantly higher adiponectin levels compared with those with stage III CKD (30.6 +/- 22.8 microg/mL vs. 21.1 +/- 14.6 microg/mL mean +/- SD, P = .05). Adiponectin was significantly correlated with gender (P = .01), high-density lipoproteins (P < .001), triglycerides (P = .004), and weight (P = .04) upon unadjusted analysis. Using multiple linear regression analysis, gender (P = .03), high-density lipoproteins (P = .001), triglycerides (P = .04), and high-sensitivity C-reactive protein (P = .004) were independently associated with adiponectin. CONCLUSIONS: Gender, high-density lipoproteins, triglycerides, and high-sensitivity C-reactive protein are major determinants of adiponectin levels in nondiabetic stage III to IV CKD. Insulin resistance, body mass index, and body fat percentage were not associated with adiponectin levels. Plasma adiponectin levels are difficult to interpret in the setting of CKD because of multiple confounders that may influence the relationship between adiponectin, adiposity, and insulin resistance.
OBJECTIVE: Our objective was to determine factors associated with adiponectin levels in subjects with stage III to IV chronic kidney disease (CKD). DESIGN: We used a cross-sectional analysis. SETTING: All kidney-disease subjects and controls were recruited at Vanderbilt University Medical Center (Nashville, TN) and Maine Medical Center (Portland, ME). PATIENTS: We recruited 95 stage III to IV CKD subjects. Kidney-disease subjects with history of diabetes mellitus were excluded from the study. INTERVENTIONS: There were no interventions. RESULTS: Subjects with stage IV CKD had significantly higher adiponectin levels compared with those with stage III CKD (30.6 +/- 22.8 microg/mL vs. 21.1 +/- 14.6 microg/mL mean +/- SD, P = .05). Adiponectin was significantly correlated with gender (P = .01), high-density lipoproteins (P < .001), triglycerides (P = .004), and weight (P = .04) upon unadjusted analysis. Using multiple linear regression analysis, gender (P = .03), high-density lipoproteins (P = .001), triglycerides (P = .04), and high-sensitivity C-reactive protein (P = .004) were independently associated with adiponectin. CONCLUSIONS: Gender, high-density lipoproteins, triglycerides, and high-sensitivity C-reactive protein are major determinants of adiponectin levels in nondiabetic stage III to IV CKD. Insulin resistance, body mass index, and body fat percentage were not associated with adiponectin levels. Plasma adiponectin levels are difficult to interpret in the setting of CKD because of multiple confounders that may influence the relationship between adiponectin, adiposity, and insulin resistance.
Authors: Luis F Ramos; Jane Kane; Ellen McMonagle; Phuong Le; Pingsheng Wu; Ayumi Shintani; Talat Alp Ikizler; Jonathan Himmelfarb Journal: J Ren Nutr Date: 2010-12-24 Impact factor: 3.655
Authors: I Kacso; A Lenghel; C I Bondor; D Moldovan; C Rusu; C Nita; N Hancu; M Gherman Caprioara; G Kacso Journal: Int Urol Nephrol Date: 2011-10-13 Impact factor: 2.370
Authors: Michael Landau; Manjula Kurella-Tamura; Michael G Shlipak; Alka Kanaya; Elsa Strotmeyer; Annemarie Koster; Suzanne Satterfield; Eleanor M Simsonick; Bret Goodpaster; Anne B Newman; Linda F Fried Journal: Nephrol Dial Transplant Date: 2011-01-19 Impact factor: 5.992
Authors: Liliane Silvano Araújo; Marcos Vinícius da Silva; Crislaine Aparecida da Silva; Maria de Fátima Borges; Heloísa Marcelina da Cunha Palhares; Laura Penna Rocha; Rosana Rosa Miranda Corrêa; Virmondes Rodrigues Júnior; Marlene Antônia Dos Reis; Juliana Reis Machado Journal: PLoS One Date: 2020-03-04 Impact factor: 3.240